Allogene Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALLO and other ETFs, options, and stocks.

About ALLO

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. 

CEO
David D. Chang
CEODavid D. Chang
Employees
361
Employees361
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2017
Founded2017
Employees
361
Employees361

ALLO Key Statistics

Market cap
768.52M
Market cap768.52M
Price-Earnings ratio
-2.13
Price-Earnings ratio-2.13
Dividend yield
Dividend yield
Average volume
3.22M
Average volume3.22M
High today
$4.57
High today$4.57
Low today
$4.36
Low today$4.36
Open price
$4.41
Open price$4.41
Volume
341.68K
Volume341.68K
52 Week high
$6.89
52 Week high$6.89
52 Week low
$2.23
52 Week low$2.23

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
31.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.